These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21518943)

  • 1. Mind or body: evaluating mind-body therapy efficacy in heart failure trials.
    Teerlink JR
    Arch Intern Med; 2011 Apr; 171(8):758-9. PubMed ID: 21518943
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of tai chi in chronic heart failure: body or mind?
    Ades PA; Wu G
    Am J Med; 2004 Oct; 117(8):611-2. PubMed ID: 15465511
    [No Abstract]   [Full Text] [Related]  

  • 3. Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivors.
    Mansky P; Sannes T; Wallerstedt D; Ge A; Ryan M; Johnson LL; Chesney M; Gerber L
    Integr Cancer Ther; 2006 Sep; 5(3):192-201. PubMed ID: 16880423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 5. Do heart failure trials need an end point committee?
    Ghali JK
    Am Heart J; 2010 Oct; 160(4):571-3. PubMed ID: 20934548
    [No Abstract]   [Full Text] [Related]  

  • 6. Key issues in end point selection for heart failure trials: composite end points.
    Neaton JD; Gray G; Zuckerman BD; Konstam MA
    J Card Fail; 2005 Oct; 11(8):567-75. PubMed ID: 16230258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem.
    Gwadry-Sridhar F; Guyatt G; O'Brien B; Arnold JM; Walter S; Vingilis E; MacKeigan L
    Contemp Clin Trials; 2008 Nov; 29(6):905-18. PubMed ID: 18703166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary heart failure clinics: are they effective in Canada?
    Rich MW
    CMAJ; 2005 Jul; 173(1):53-4. PubMed ID: 15997045
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 10. Resynchronization therapy for the treatment of heart failure.
    Saxon LA; Ellenbogen KA
    Circulation; 2003 Sep; 108(9):1044-8. PubMed ID: 12952826
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 12. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.
    Le Cleach L; Chassany O; Levy A; Wolkenstein P; Chosidow O
    Dermatology; 2008; 216(1):46-55. PubMed ID: 18032899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size determination and statistical power in randomized controlled trials.
    Sjögren P; Hedström L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries of nursing care-related systematic reviews from the Cochrane library: erythropoiesis-stimulating agents for anemia in chronic heart failure patients.
    Barrett D
    J Cardiovasc Nurs; 2010; 25(5):381-2. PubMed ID: 20714234
    [No Abstract]   [Full Text] [Related]  

  • 15. Can vitamin D supplementation improve physical function and quality of life in older patients with heart failure?
    Levitan EB; Judd SE
    Circ Heart Fail; 2010 Mar; 3(2):183-4. PubMed ID: 20233991
    [No Abstract]   [Full Text] [Related]  

  • 16. Early average change in tumor size in a phase 2 trial: efficient endpoint or false promise?
    Rubinstein LV; Dancey JE; Korn EL; Smith MA; Wright JJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1422-3. PubMed ID: 17895470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Meditation for heart conditions].
    Wepner U
    MMW Fortschr Med; 2006 Mar; 148(13):10, 13. PubMed ID: 16642696
    [No Abstract]   [Full Text] [Related]  

  • 18. A global rank end point for clinical trials in acute heart failure.
    Felker GM; Maisel AS
    Circ Heart Fail; 2010 Sep; 3(5):643-6. PubMed ID: 20841546
    [No Abstract]   [Full Text] [Related]  

  • 19. Pros and cons of composite endpoints in anesthesia trials.
    Myles PS; Devereaux PJ
    Anesthesiology; 2010 Oct; 113(4):776-8. PubMed ID: 20808209
    [No Abstract]   [Full Text] [Related]  

  • 20. Tai Chi for chronic heart failure.
    Cheng TO
    Int J Cardiol; 2006 Jun; 110(1):96. PubMed ID: 16723290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.